SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054522
Filing Date
2021-11-04
Accepted
2021-11-04 16:43:25
Documents
60
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avro-10q_20210930.htm   iXBRL 10-Q 2255159
2 EX-10.1 avro-ex101_41.htm EX-10.1 656650
3 EX-31.1 avro-ex311_7.htm EX-31.1 17721
4 EX-31.2 avro-ex312_8.htm EX-31.2 17793
5 EX-32.1 avro-ex321_6.htm EX-32.1 10863
  Complete submission text file 0001564590-21-054522.txt   7107852

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA avro-20210930.xsd EX-101.SCH 41791
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avro-20210930_cal.xml EX-101.CAL 29208
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avro-20210930_def.xml EX-101.DEF 112868
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20210930_lab.xml EX-101.LAB 321827
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20210930_pre.xml EX-101.PRE 229443
11 EXTRACTED XBRL INSTANCE DOCUMENT avro-10q_20210930_htm.xml XML 931014
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 211380574
SIC: 2836 Biological Products, (No Diagnostic Substances)